Chronic high-frequency deep-brain stimulation in progressive myoclonic epilepsy in adulthood - Report of five cases

Epilepsia

Volumn 52, Issue 3, 2011, Pages 489-496

  Wille, Christian ^a,b   Steinhoff, Bernhard J ^c   Altenmüller, Dirk Matthias ^b   Staack, Anke Maren ^c   Bilic, Sofia ^c   Nikkhah, Guido ^b   Vesper, Jan ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Epilepsiezentrum Kork   (Germany)

Author keywords

Deep brain stimulation; Myoclonic epilepsy; Stereotaxy; Surgery

Indexed keywords

CLOBAZAM; CLONAZEPAM; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; PIRACETAM; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADULT; ARTICLE; BRAIN; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DAILY LIFE ACTIVITY; ELECTRODE; FEMALE; FOLLOW UP; GRAND MAL SEIZURE; HUMAN; MALE; MOTOR PERFORMANCE; MUSCLE REFLEX; MYOCLONUS; MYOCLONUS EPILEPSY; PATIENT SAFETY; PRIORITY JOURNAL; STANDING; SUBSTANTIA NIGRA PARS RETICULATA; SUBTHALAMIC NUCLEUS; THERAPY EFFECT; TONIC CLONIC SEIZURE; VENTRAL INTERMEDIATE NUCLEUS; WALKING;

ADULT; ANTICONVULSANTS; COMBINED MODALITY THERAPY; DEEP BRAIN STIMULATION; DOMINANCE, CEREBRAL; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; MALE; SIGNAL PROCESSING, COMPUTER-ASSISTED; STEREOTAXIC TECHNIQUES; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; VENTRAL THALAMIC NUCLEI;

EID: 79952555803     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02884.x     Document Type: Article

References (37)

1. Andrade DM, Zumsteg D, Hamani C, Hodaie M, Sarkissian S, Lozano AM, Wennberg RA. (2006) Long-term follow-up of patients with thalamic deep brain stimulation for epilepsy. Neurology 66:1571-1573. (Pubitemid 43958559)
2. Aykutlu E, Baykan B, Gurses C, Bebek N, Buyukbabani N, Gokyigit A. (2005) Add-on therapy with topiramate in progressive myoclonic epilepsy. Epilepsy Behav 6:260-263. (Pubitemid 40247163)
3. Benabid AL, Koudsie A, Benazzouz A, Vercueil L, Fraix V, Chabardes S, Lebas JF, Pollak P. (2001) Deep brain stimulation of the corpus luysi (subthalamic nucleus) and other targets in Parkinson's disease. Extension to new indications such as dystonia and epilepsy. J Neurol 248(suppl 3):III37-III47.
4. Chabardes S, Kahane P, Minotti L, Koudsie A, Hirsch E, Benabid AL. (2002) Deep brain stimulation in epilepsy with particular reference to the subthalamic nucleus. Epileptic Disord 4(suppl 3):S83-S93. (Pubitemid 36292116)
5. Commission on Classification and Terminology of the International League Against Epilepsy. (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389-399.
6. Conry JA. (2002) Progressive myoclonic epilepsies. J Child Neurol 17(suppl 1):S80-S84.
7. Conry JA. (2004) Pharmacologic treatment of the catastrophic epilepsies. Epilepsia 45(suppl 5):12-16.
8. Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B. (1998) Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 39:81-88. (Pubitemid 28116846)
9. Crest C, Dupont S, Leguern E, Adam C, Baulac M. (2004) Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients. Neurology 62:640-643. (Pubitemid 38252812)
10. Dinner DS, Neme S, Nair D, Montgomery EB Jr, Baker KB, Rezai A, Luders HO. (2002) EEG and evoked potential recording from the subthalamic nucleus for deep brain stimulation of intractable epilepsy. Clin Neurophysiol 113:1391-1402.
11. Fisher R, Salanova V, Witt T, Worth R, Henry T, Gross R, Oommen K, Osorio I, Nazzaro J, Labar D, Kaplitt M, Sperling M, Sandok E, Neal J, Handforth A, Stern J, DeSalles A, Chung S, Shetter A, Bergen D, Bakay R, Henderson J, French J, Baltuch G, Rosenfeld W, Youkilis A, Marks W, Garcia P, Barbaro N, Fountain N, Bazil C, Goodman R, McKhann G, Babu KK, Papavassiliou S, Epstein C, Pollard J, Tonder L, Grebin J, Coffey R, Graves N. (2010) Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 51:899-908.
12. Genton P, Guerrini R. (1990) Antimyoclonic effects of alcohol in progressive myoclonus epilepsy. Neurology 40:1412-1416. (Pubitemid 20291651)
13. Hamrin E, Wohlin A. (1982) I. Evaluation of the functional capacity of stroke patients through an activity index. Scand J Rehabil Med 14:93-100. (Pubitemid 12009840)
14. Hodaie M, Wennberg RA, Dostrovsky JO, Lozano AM. (2002) Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia 43:603-608. (Pubitemid 34627719)
15. Kalviainen R, Khyuppenen J, Koskenkorva P, Eriksson K, Vanninen R, Mervaala E. (2008) Clinical picture of EPM1-Unverricht-Lundborg disease. Epilepsia 49:549-556. (Pubitemid 351661066)
16. Kupsch A, Trottenberg T, Meissner W, Funk T. (1999) Neurostimulation of the ventral intermediate thalamic nucleus alleviates hereditary essential myoclonus. J Neurol Neurosurg Psychiatry 67:415-416. (Pubitemid 29392614)
17. Lim SN, Lee ST, Tsai YT, Chen IA, Tu PH, Chen JL, Chang HW, Su YC, Wu T. (2007) Electrical stimulation of the anterior nucleus of the thalamus for intractable epilepsy: a long-term follow-up study. Epilepsia 48:342-347.
18. Loscher W, Ebert U, Lehmann H, Rosenthal C, Nikkhah G. (1998) Seizure suppression in kindling epilepsy by grafts of fetal GABAergic neurons in rat substantia nigra. J Neurosci Res 51:196-209. (Pubitemid 28073027)
19. Magaudda A, Ferlazzo E, Nguyen VH, Genton P. (2006) Unverricht- Lundborg disease, a condition with self-limited progression: long-term follow-up of 20 patients. Epilepsia 47:860-866. (Pubitemid 44030180)
20. Mancuso M, Galli R, Pizzanelli C, Filosto M, Siciliano G, Murri L. (2006) Antimyoclonic effect of levetiracetam in MERRF syndrome. J Neurol Sci 243:97-99.
21. Manganotti P, Tamburin S, Zanette G, Fiaschi A. (2001) Hyperexcitable cortical responses in progressive myoclonic epilepsy: a TMS study. Neurology 57:1793-1799. (Pubitemid 33096685)
22. Paulus W, Ried S, Stodieck SR, Schmidt D. (1991) Abolition of photoparoxysmal response in progressive myoclonus epilepsy. Eur Neurol 31:388-390.
23. Perozzo P, Rizzone M, Bergamasco B, Castelli L, Lanotte M, Tavella A, Torre E, Lopiano L. (2001) Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: comparison of pre- and postoperative neuropsychological evaluation. J Neurol Sci 192:9-15. (Pubitemid 32999018)
24. Pohlmann-Eden B, Peters CN, Wennberg R, Dempfle CE. (2003) Valproate induces reversible factor XIII deficiency with risk of perioperative bleeding. Acta Neurol Scand 108:142-145. (Pubitemid 36920666)
25. Pranzatelli MR, Tate ED. (2001) Chloral hydrate for progressive myoclonus epilepsy: a new look at an old drug. Pediatr Neurol 25:385-389.
26. Shahwan A, Farrell M, Delanty N. (2005) Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 4:239-248. (Pubitemid 40381111)
27. Shon YM, Lee KJ, Kim HJ, Chung YA, Ahn KJ, Kim YI, Yang DW, Kim BS. (2005) Effect of chronic deep brain stimulation of the subthalamic nucleus for frontal lobe epilepsy: subtraction SPECT analysis. Stereotact Funct Neurosurg 83:84-90.
28. Smith B, Shatz R, Elisevich K, Bespalova IN, Burmeister M. (2000) Effects of vagus nerve stimulation on progressive myoclonus epilepsy of Unverricht-Lundborg type. Epilepsia 41:1046-1048. (Pubitemid 30640873)
29. Uthman BM, Reichl A. (2002) Progressive Myoclonic Epilepsies. Curr Treat Options Neurol 4:3-17.
30. Velasco F, Velasco AL, Velasco M, Jimenez F, Carrillo-Ruiz JD, Castro G. (2007) Deep brain stimulation for treatment of the epilepsies: the centromedian thalamic target. Acta Neurochir Suppl 97 (Pt 2):337-342.
31. Vesper J, Chabardes S, Fraix V, Sunde NA, Ostergaard K. (2002) Dual Channel Deep Brain Stimulation System (Kinetra™) for Parkinson's Disease and Essential Tremor - A prospective multicenter open label clinical study. J Neurol Neurosurg Psychiatry 73: 275-280.
32. Vesper J, Steinhoff B, Rona S, Wille C, Bilic S, Nikkhah G, Ostertag C. (2007) Chronic high-frequency deep brain stimulation of the STN/SNr for progressive myoclonic epilepsy. Epilepsia 48:1984-1989. (Pubitemid 47537447)
33. Vingerhoets FJ, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J. (2002) Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 58:396-401. (Pubitemid 34150913)
34. Vonck K, Boon P, Goossens L, Dedeurwaerdere S, Claeys P, Gossiaux F, Van Hese P, De Smedt T, Raedt R, Achten E, Deblaere K, Thieleman A, Vandemaele P, Thiery E, Vingerhoets G, Miatton M, Caemaert J, Van Roost D, Baert E, Michielsen G, Dewaele F, Van Laere K, Thadani V, Robertson D, Williamson P. (2003) Neurostimulation for refractory epilepsy. Acta Neurol Belg 103:213-217. (Pubitemid 38262542)
35. Vossler DG, Conry JA, Murphy JV. (2008) Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open-label study. Epileptic Disord 10:31-34. (Pubitemid 351507324)
36. Wider C, Pollo C, Bloch J, Burkhard PR, Vingerhoets FJ. (2008) Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord 14:114-119. (Pubitemid 351735982)
37. Zumsteg D, Lozano AM, Wieser HG, Wennberg RA. (2006) Cortical activation with deep brain stimulation of the anterior thalamus for epilepsy. Clin Neurophysiol 117:192-207. (Pubitemid 43099964)